Parkinson’s disease and gene therapy: strategic and operational…
- Magazine Article - PharmaTimes
by Andreas Schreiner, MD, is vice president, medical affairs, neuroscience and analgesia and April Marquick, PhD, is cell and gene therapy expert and senior regulatory start-up manager, both at Premier Research
https://www.pharmatimes.com/magazine/2021/december_2021/parkinsons_disease_and_gene_therapy_strategic_and_operational_considerations2